DiaSorin SpA
Neal Domeyer is a seasoned financial professional with extensive experience in various controller roles across multiple industries. Currently serving as Senior Controller at DiaSorin since April 2008, Neal oversees financial operations for a leading manufacturer and distributor in the clinical reference laboratory diagnostics market. Prior to this, Neal held positions as Controller at Protient Inc., Arden Architectural Specialties, and Johnson Grossfield, contributing to financial management and reporting in both manufacturing and marketing sectors. Neal holds a Bachelor of Arts in Accounting and a Masters of Business Administration with a focus on Management from the University of St. Thomas.
This person is not in any offices
DiaSorin SpA
4 followers
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.